STEREOTAXIS INC (STXS) Stock Fundamental Analysis

NYSEARCA:STXS • US85916J4094

2.2 USD
+0.1 (+4.76%)
At close: Feb 25, 2026
2.23 USD
+0.03 (+1.36%)
After Hours: 2/25/2026, 6:33:22 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

Overall STXS gets a fundamental rating of 2 out of 10. We evaluated STXS against 185 industry peers in the Health Care Equipment & Supplies industry. While STXS seems to be doing ok healthwise, there are quite some concerns on its profitability. STXS is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year STXS has reported negative net income.
  • In the past year STXS has reported a negative cash flow from operations.
  • STXS had negative earnings in each of the past 5 years.
  • STXS had a negative operating cash flow in each of the past 5 years.
STXS Yearly Net Income VS EBIT VS OCF VS FCFSTXS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M -20M -25M

1.2 Ratios

  • STXS has a worse Return On Assets (-59.84%) than 69.73% of its industry peers.
  • STXS has a Return On Equity of -364.90%. This is in the lower half of the industry: STXS underperforms 78.92% of its industry peers.
Industry RankSector Rank
ROA -59.84%
ROE -364.9%
ROIC N/A
ROA(3y)-47.89%
ROA(5y)-35.58%
ROE(3y)-127.97%
ROE(5y)-86.89%
ROIC(3y)N/A
ROIC(5y)N/A
STXS Yearly ROA, ROE, ROICSTXS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150 -200

1.3 Margins

  • With a Gross Margin value of 50.17%, STXS perfoms like the industry average, outperforming 44.32% of the companies in the same industry.
  • In the last couple of years the Gross Margin of STXS has declined.
  • The Profit Margin and Operating Margin are not available for STXS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 50.17%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.5%
GM growth 5Y-7.2%
STXS Yearly Profit, Operating, Gross MarginsSTXS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • STXS does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for STXS has been increased compared to 1 year ago.
  • STXS has more shares outstanding than it did 5 years ago.
  • There is no outstanding debt for STXS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
STXS Yearly Shares OutstandingSTXS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
STXS Yearly Total Debt VS Total AssetsSTXS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • STXS has an Altman-Z score of -17.16. This is a bad value and indicates that STXS is not financially healthy and even has some risk of bankruptcy.
  • STXS has a Altman-Z score of -17.16. This is amonst the worse of the industry: STXS underperforms 87.03% of its industry peers.
  • There is no outstanding debt for STXS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -17.16
ROIC/WACCN/A
WACC9.86%
STXS Yearly LT Debt VS Equity VS FCFSTXS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

2.3 Liquidity

  • A Current Ratio of 1.06 indicates that STXS should not have too much problems paying its short term obligations.
  • The Current ratio of STXS (1.06) is worse than 85.41% of its industry peers.
  • A Quick Ratio of 0.59 indicates that STXS may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.59, STXS is not doing good in the industry: 90.27% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 0.59
STXS Yearly Current Assets VS Current LiabilitesSTXS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The earnings per share for STXS have decreased by 0.00% in the last year.
  • Looking at the last year, STXS shows a small growth in Revenue. The Revenue has grown by 0.55% in the last year.
  • The Revenue has been decreasing by -1.41% on average over the past years.
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.5%
Revenue 1Y (TTM)0.55%
Revenue growth 3Y-8.4%
Revenue growth 5Y-1.41%
Sales Q2Q%-18.83%

3.2 Future

  • STXS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.84% yearly.
  • The Revenue is expected to grow by 28.33% on average over the next years. This is a very strong growth
EPS Next Y14.39%
EPS Next 2Y16.48%
EPS Next 3Y17.84%
EPS Next 5YN/A
Revenue Next Year20.4%
Revenue Next 2Y25.03%
Revenue Next 3Y28.33%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
STXS Yearly Revenue VS EstimatesSTXS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M 50M
STXS Yearly EPS VS EstimatesSTXS Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 -0.05 -0.1 -0.15 -0.2 -0.25

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • STXS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year STXS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
STXS Price Earnings VS Forward Price EarningsSTXS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
STXS Per share dataSTXS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2

4.3 Compensation for Growth

  • A more expensive valuation may be justified as STXS's earnings are expected to grow with 17.84% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y16.48%
EPS Next 3Y17.84%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • STXS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

STEREOTAXIS INC

NYSEARCA:STXS (2/25/2026, 6:33:22 PM)

After market: 2.23 +0.03 (+1.36%)

2.2

+0.1 (+4.76%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-11
Earnings (Next)03-09
Inst Owners46.53%
Inst Owner Change0.55%
Ins Owners19.06%
Ins Owner Change5.15%
Market Cap205.30M
Revenue(TTM)26.92M
Net Income(TTM)-24.64M
Analysts81.82
Price Target4.28 (94.55%)
Short Float %4.26%
Short Ratio5.19
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.96%
Min EPS beat(2)5.34%
Max EPS beat(2)24.59%
EPS beat(4)2
Avg EPS beat(4)-13.8%
Min EPS beat(4)-49.39%
Max EPS beat(4)24.59%
EPS beat(8)3
Avg EPS beat(8)-12.25%
EPS beat(12)5
Avg EPS beat(12)-9.56%
EPS beat(16)7
Avg EPS beat(16)-10.57%
Revenue beat(2)2
Avg Revenue beat(2)6.35%
Min Revenue beat(2)6.15%
Max Revenue beat(2)6.54%
Revenue beat(4)3
Avg Revenue beat(4)9.1%
Min Revenue beat(4)-3.27%
Max Revenue beat(4)26.98%
Revenue beat(8)3
Avg Revenue beat(8)-4.79%
Revenue beat(12)4
Avg Revenue beat(12)-4.19%
Revenue beat(16)6
Avg Revenue beat(16)-3.64%
PT rev (1m)0%
PT rev (3m)-1.18%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-9.48%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.69%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.17%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.45
P/FCF N/A
P/OCF N/A
P/B 30.41
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.28
EYN/A
EPS(NY)-0.19
Fwd EYN/A
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS0.34
BVpS0.07
TBVpS-0.04
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -59.84%
ROE -364.9%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 50.17%
FCFM N/A
ROA(3y)-47.89%
ROA(5y)-35.58%
ROE(3y)-127.97%
ROE(5y)-86.89%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.5%
GM growth 5Y-7.2%
F-Score4
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2.39%
Cap/Sales 0.11%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.06
Quick Ratio 0.59
Altman-Z -17.16
F-Score4
WACC9.86%
ROIC/WACCN/A
Cap/Depr(3y)206.17%
Cap/Depr(5y)389.02%
Cap/Sales(3y)3.32%
Cap/Sales(5y)2.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.5%
EPS Next Y14.39%
EPS Next 2Y16.48%
EPS Next 3Y17.84%
EPS Next 5YN/A
Revenue 1Y (TTM)0.55%
Revenue growth 3Y-8.4%
Revenue growth 5Y-1.41%
Sales Q2Q%-18.83%
Revenue Next Year20.4%
Revenue Next 2Y25.03%
Revenue Next 3Y28.33%
Revenue Next 5YN/A
EBIT growth 1Y-12.25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year64.2%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y26.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y20.75%
OCF growth 3YN/A
OCF growth 5YN/A

STEREOTAXIS INC / STXS FAQ

What is the ChartMill fundamental rating of STEREOTAXIS INC (STXS) stock?

ChartMill assigns a fundamental rating of 2 / 10 to STXS.


What is the valuation status of STEREOTAXIS INC (STXS) stock?

ChartMill assigns a valuation rating of 0 / 10 to STEREOTAXIS INC (STXS). This can be considered as Overvalued.


Can you provide the profitability details for STEREOTAXIS INC?

STEREOTAXIS INC (STXS) has a profitability rating of 0 / 10.


How financially healthy is STEREOTAXIS INC?

The financial health rating of STEREOTAXIS INC (STXS) is 4 / 10.